Results 31 to 40 of about 1,197,472 (281)

Management of clinical precision medicine

Clinical and Translational Discovery, 2021
Precision medicine is an emerging approach for patient treatment as it allows clinicians to select therapies based on the genetic understanding of the disease.
Hao Chen, Mengjia Qian, Lili Ji, Feng Li, Yunfeng Cheng   +4 more
doaj   +1 more source

Biomarkers in cardiovascular medicine: towards precision medicine

Swiss Medical Weekly, 2019
Biomarkers are noninvasive, inexpensive, highly reproducible tools that allow clinicians to quantify pathophysiological processes relevant to a specific disease. Although the concept of biomarker-guided precision medicine is still in its infancy once a
Danielle Menosi Gualandro, Raphael Twerenbold, Jasper Boeddinghaus, Thomas Nestelberger, Christian Puelacher, Christian Mueller   +5 more
doaj   +1 more source

Snapshot: Trial Types in Precision Medicine. [PDF]

, 2020
Integrating precision diagnostics into personalized treatments requires understanding how biomarkers relate to clinical outcomes. Various clinical data collection methods exist, each with strengths and weaknesses. Interventional data are high quality but
Bergan, Raymond, Dickson, Dane, Johnson, Jennifer, Kurzrock, Razelle, Owens, Rebecca, Subbiah, Vivek   +5 more
core  

The Half-lives of $^{132}$La and $^{135}$La [PDF]

, 2017
The half-lives of $^{135}$La and $^{132}$La were determined via gamma spectroscopy and high-precision ionization chamber measurements. The results are 18.930(6) h for $^{135}$La and 4.59(4) h for $^{132}$La compared to the previously compiled values of ...
Abel, E. P., Clause, H. K., Fonslet, J., Nickles, R. J., Severin, G. W.   +4 more
core   +2 more sources

FROM PERSONALIZED TO PRECISION MEDICINE

Рациональная фармакотерапия в кардиологии, 2017
The need to maintain a high quality of life against a backdrop of its inevitably increasing duration is one of the main problems of modern health care.
K. V. Raskina, E. Y. Martynova, A. V. Perfilyev, D. A. Sychev, G. N. Shuev, I. R. Fatkhutdinov, S. V. Musienko, D. A. Nikogosov, I. O. Zhegulina, L. G. Bavykina, Y. E. Poteshkin   +10 more
doaj   +1 more source

Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells. [PDF]

, 2017
Precision cancer medicine seeks to target the underlying genetic alterations of cancer; however, it has been challenging to use genetic profiles of individual patients in identifying the most appropriate anti-cancer drugs. This spurred the development of
Dall'Era, Marc A, de Vere White, Ralph W, Gheibi, Pantea, Ma, Ai-Hong, Pan, Chong-Xian, Revzin, Alexander, Son, Kyung Jin, Vu, Tam, Yap, Stanley Alexander, Zeng, Shuxiong   +9 more
core   +2 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Precision Medicine and Pediatric Epilepsy

Archives of Epilepsy, 2022
Recently, it is time to shift from a reactive attitude that treats patients after the onset of seizures to a proactive one integrated into a broader “P4 medicine” approach in the treatment of epilepsy.
Aycan Ünalp, Erdem Adalıoğlu
doaj   +1 more source

Coronary Physiology: Delivering Precision Medicine?

Reviews in Cardiovascular Medicine, 2022
Coronary physiological assessment is now widely used to assess epicardial coronary lesions in cath lab. Based on clinical evidence, fractional flow reserve (FFR) is the gold standard method to select whether epicardial coronary lesions need ...
Laura Maitre-Ballesteros, Laurent Riou, Stephanie Marliere, Marjorie Canu, Estelle Vautrin, Nicola Piliero, Oliviez Ormezzano, Helene Bouvaist, Alexis Broisat, Catherine Ghezzi, Daniel Fagret, Gérald Vanzetto, Loïc Djaïleb, Gilles Barone-Rochette   +13 more
doaj   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source